Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:
A female stockbroker reviews share price performance in her office with the city shown in the background through her windows

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Life360 Inc (ASX: 360)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating on this location technology company's shares with an improved price target of $17.50. This follows the release of a quarterly update last week. The broker notes that Life360's update, which was largely pre-released, revealed that its strong growth not only continued in the quarter but also at the start of the new quarter. In light of this very positive momentum, Morgan Stanley has boosted its earnings estimates for the coming years and its valuation for the company accordingly. The Life360 share price is trading at $15.50 on Monday afternoon.

Orica Ltd (ASX: ORI)

A note out of Goldman Sachs reveals that its analysts have resumed coverage on this commercial explosives company's shares with a buy rating and $21.20 price target. The broker was impressed with Orica's performance during the first half, noting that its profits were comfortably ahead of both its own and the market's expectations. In light of this, the broker is feeling even more positive about the company's outlook. Particularly given its belief that commercial discipline in a balanced ammonium nitrate market will drive uplift in profitability, and that recent acquisitions augment the platform to capture incremental customer share of wallet. This has led to the broker lifting its earnings forecasts accordingly. The Orica share price is fetching $18.16 at the time of writing.

QBE Insurance Group Ltd (ASX: QBE)

Another note out of Goldman Sachs reveals that its analysts have retained their buy rating on this insurance giant's shares with an improved price target of $20.90. This follows the release of a quarterly update that was described as operationally strong. The broker believes some of management's decisions signal confidence in the company's capital position and return on equity. It also thinks there is small underlying margin upside risk based on current running yields. All in all, the broker remains positive and highlights that QBE has the strongest exposure to the commercial rate cycle. The QBE share price is trading at $17.51 on Monday.

Motley Fool contributor James Mickleboro has positions in Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Life360. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 300 shares could rise 35% to 65%

Analysts are tipping these shares to rise strongly from current levels. How high could they go?

Read more »

a man in a high visibility vest and hard hat holds a thumbs up at a mine site with heavy equipment in the background.
Broker Notes

What are brokers saying about BHP shares following the miner's quarterly results?

Analysts have crunched the numbers.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Man on a laptop thinking.
Broker Notes

Why did Goldman Sachs just downgrade Wesfarmers shares?

The ASX 200 conglomerate has had a ripper run of share price growth. So why is Goldman Sachs downgrading it?

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why these 4 ASX 200 shares just got downgraded by top brokers

Leading brokers have downgraded their outlooks for these ASX 200 shares. But why?

Read more »

Investor sitting in front of multiple screens watching share prices
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Why this beaten-down ASX 200 stock can jump 24%

Goldman Sachs thinks this sold off stock could generate big returns for investors.

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Broker Notes

ResMed shares higher as company 'turns the GLP threat into an opportunity': Fundie

ResMed is having a great run in 2024 with the share price up 29% already.

Read more »